Categories: Business

J&J doubles down on neurological drugs with $14.6 billion intracellular deal – Reuters

  1. J&J doubles down on neurological drugs with $14.6 billion intracellular deal Reuters
  2. J&J closes $14.6 billion deal for intracellular therapies Axios
  3. J&J deepens neuropsychology with $14.6 billion acquisition Investor Business Daily
  4. J&J buys psychiatric drug developer Intra-Cellular for $14.6 billion BioPharma Diving
  5. Johnson & Johnson in talks to acquire intracellular therapies Yahoo Finance
remon Buul

Recent Posts

Greenland ready to work with US on defense, says PM

Greenland wants to work more closely with the United States in the areas of defense…

8 minutes ago

The sell-off in global bonds deepens as investors lower their expectations for a Fed rate cut.

The Eccles Building, home of the Board of Governors of the Federal Reserve and the…

11 minutes ago

Beyoncé delays January 14 announcement due to LA fires

Beyoncé is postponing her highly anticipated announcement, scheduled for January 14, amid the devastation caused…

12 minutes ago

Frontier Airlines Releases Statement Regarding Khabib Nurmagomedov’s Removal From Flight

Frontier Airlines has now addressed the viral video showing retired UFC champion Khabib Nurmagomedov being…

15 minutes ago

NFL wild-card round winners and losers: Sam Darnold costs himself millions with terrible two-game finish

Legacies are often defined in the playoffs. This fact was highlighted during the 2024 NFL…

24 minutes ago

Universal Music cancels Grammy Week events due to LA fires

Universal Music Group has canceled all of its Grammy-related events, including Saturday's artist showcase and…

28 minutes ago